PATENT CLAIM ANALYSIS

Application Number: 16211684
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["424", "093400"]

Abstract:
The present disclosure provides methods and treatment regimens for treating ulcerative colitis in a subject in need thereof. In particular, the methods described herein comprise treating a subject in need thereof with a treatment regimen comprising the administration of a pharmaceutical composition comprising live non-pathogenic fecal bacteria for at least 8 weeks and at least three times per week. In an aspect, the subject in need thereof exhibits a Mayo endoscopy score of 3 or lower. In some aspects, the subject in need thereof has no concomitant corticosteroid use during said method and has no corticosteroid use immediately prior to commencing said method.

Claim (Index 37):
The method of  claim 22 , wherein the method further comprises determining the level of one or more bacteria selected from the group consisting of  Fusobacterium, Sutterella, Barnesiella, Parabacteroides, Clostridium  IV,  Ruminococcus, Blautia, Dorea, Ruminococcus 2, and  Clostridium  XVIII in the subject's gut.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.64179
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15791868', '15155628', '15594319', '15626880', '15594087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.734017943748935
- 35 USC 102 Novelty (BERT): 0.6961995641651803
- Combined Prediction Score: 0.7302361057905595
- Mean Citation Score: 367.685458
- Max Citation Score: 668.3216
- Similarity Product: 605.3312777078629

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test